Las Vegas, NV – June 25, 2013 — (Tech Sonian) – NYBD Holding Inc (OTCMKTS:NYBD) is pleased to proclaim we have filed for a name change and have been received . NYBD Holdings will adopt its new name Pleasant Kids, Inc. (AQUA) to coincide with the launch of our “WHERE HEALTHY BEGINS” campaign and the launch of our Organic Apple Juice Beverage.
NYBD Holding Inc (OTCMKTS:NYBD) reported 165.21 million shares has been exchanged so far while the average volume is about 205.03 million shares. The stock is same and most recently was trading at $0.0013. The beta of the stock is recorded at 2.67 and the EPS of the stock remained -0.03. The shares outstanding of the stock are 1.10 billion.
Why Should Investors Buy NYBD After The Recent Gain? Just Go Here and Find Out
Nuvilex Inc (OTCMKTS:NVLX) can achieve more in its upcoming preclinical trials than many may realize. With the declaration that Translational Drug Development (TD2) will be conducting the preclinical studies and clinical trials that will follow to study the Maryland biotech’s pancreatic cancer treatment and its ability to relieve symptoms associated with the deadly cancer, Nuvilex entered into a high profile opportunity.
Looking at Nuvilex Inc (OTCMKTS:NVLX), itsvolume so far was 0.245 million shares as compared to the average volume of 2.12 million shares. The stock boosted +0.58% in its today’s trading session and was trading at a price of $0.279.
For How Long NVLX will Fight for Profitability? Read This Trend Analysis report
Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) publicized the expansion of responsibilities for three members of its senior management team. The additional operational responsibilities, now at the senior management level, include Operations, Project Management, and Reimbursement Planning.
Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) was trading with a volume of 0.173 million shares versus the average volume of the stock 0.186 million shares. The stock decreased -2.97% and was recently trading at $0.980. The market capitalization of the stock remained 91.16 million. The beta of the stock was 14.89.
Why Should Investors Buy NVIV After the Recent Fall? Just Go Here and Find Out
NOVAGANT CORP. (OTCMKTS:NVGT) is pleased to publicize its new medical cannabis vaporizer product, GLAVape™ (Generally Legal American Vape), which is the finest and most consistent Cannabidiol (CBD)-rich hemp oil in the world.
In the current trading day, NOVAGANT CORP. (OTCMKTS:NVGT)enhanced +1.47% to move at $0.345. The volume of the stock was 2.03 million shares and the average volume remained 26,676 shares. The stock, at last check, has the day price range of $0.34 – $0.41. The market capitalization was recorded at 95.60 million. The beta of the stock remained -78.73.
Will NVGT Continue To Move Higher? Find Out Here